Last updated at 17 Jul 2024 03:27 PM
Director
DIN: 06464627
Ramadasan Raghunath Ayyangar is currently associated with 3 companies in various capacities such as Director, Designated Partner and Additional Director. They serve as a Director at KML CHEMICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06464627.Ramadasan Raghunath Ayyangar is currently involved in 3 different roles. Their most recent position is with CYNTHOGEN PHARMACEUTICALS PRIVATE LIMITED as a Additional Director. The first company Ramadasan Raghunath Ayyangar was appointed to as a director was KML CHEMICALS PRIVATE LIMITED. Ramadasan Raghunath Ayyangar is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Ramadasan Raghunath Ayyangar is currently associated with 3 companies in various capacities such as Director, Designated Partner and Additional Director. They serve as a Director at KML CHEMICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06464627.Ramadasan Raghunath Ayyangar is currently involved in 3 different roles. Their most recent position is with CYNTHOGEN PHARMACEUTICALS PRIVATE LIMITED as a Additional Director. The first company Ramadasan Raghunath Ayyangar was appointed to as a director was KML CHEMICALS PRIVATE LIMITED. Ramadasan Raghunath Ayyangar is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (1)
Past Companies (0)
2y 7m 1y 4m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| KML CHEMICALS PRIVATE LIMITED | Director | 28-Dec-2012 |
| CYNTHOGEN PHARMACEUTICALS PRIVATE LIMITED | Additional Director | 04-Apr-2024 |